UNIVERSITE DE MONTPELLIER
Patent Owner
Stats
- 31 US PATENTS IN FORCE
- 16 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 31 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 594 Total Citation Count
- Sep 06, 2004 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0239,237 PYRROLOQUINOLINE DERIVATIVES AS 5-HT6 ANTAGONISTS, PREPARATION METHOD AND USE THEREOFMay 05, 17Aug 24, 17[A61K]
2017/0211,151 METHODS FOR PREDICTING RESPONSE TO DNA REPAIR PATHWAY INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMAJul 27, 15Jul 27, 17[C12Q, G06F]
2017/0197,938 A QUINOLINE DERIVATIVE FOR THE TREATMENT OF INFLAMMATORY DISEASES AND AIDSJul 17, 15Jul 13, 17[C07D]
2017/0183,742 METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS SUFFERING FROM CANCERMay 27, 15Jun 29, 17[C12Q]
2017/0110,611 MULTIPLE-JUNCTION PHOTOVOLTAIC CELL BASED ON ANTIMONIDE MATERIALSMay 20, 15Apr 20, 17[H01L]
2017/0096,710 METHODS FOR PREDICTING RESPONSE TO HDACI/DNMTI COMBINATION IN MULTIPLE MYELOMAMar 20, 15Apr 06, 17[A61K, C12Q, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9890112 Compounds for use as therapeutic agents affecting p53 expression and/or activityApr 02, 12Feb 13, 18[A61K, C07D, C07C]
9774165 Vertical external cavity surface emitting laser devices allowing high coherence, high power and large tunabilityMay 21, 15Sep 26, 17[H01S]
9765339 FLT3 receptor antagonists for the treatment or the prevention of pain disordersJul 08, 15Sep 19, 17[A61K, C07H, C12N, G01N, C07K]
9688990 Methods and pharmaceutical compositions for treatment of cystic fibrosisSep 12, 14Jun 27, 17[A61K, C12N]
9611481 Chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereofSep 23, 10Apr 04, 17[A61K, C12Q, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0083,712 CSN5 POLYPEPTIDES AND USES THEREOF FOR SCREENING THERAPEUTIC AGENTSAbandonedOct 14, 13Mar 24, 16[C12N, G01N]
2015/0376,216 SUGAR-ANALOG PHOSPHORUS-CONTAINING HETEROCYCLES HAVING AN ANTI-METASTATIC ACTIVITYAbandonedFeb 25, 14Dec 31, 15[A61K, C07F]
2015/0297,573 TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING Beta-CELL SURVIVALAbandonedOct 24, 13Oct 22, 15[A61K]
2015/0259,403 Methods and Pharmaceutical Compositions for Treatment of Gastrointestinal Stromal TumorsAbandonedOct 10, 13Sep 17, 15[A61K, C12Q, G01N, C07K]
2015/0037,282 D-AMINO ACID PHOSPHORAMIDATE PRONUCLEOTIDES OF HALOGENO PYRIMIDINE COMPOUNDS FOR LIVER DISEASEAbandonedJul 31, 14Feb 05, 15[C07H, A61K]
2014/0148,363 Methods for Selecting Oocytes and Competent Embryos with High Potential for Pregnancy OutcomeAbandonedJan 30, 14May 29, 14[C12Q]
8067338 Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrateExpiredNov 28, 05Nov 29, 11[C07F, C40B]
2008/0279,855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical CompositionsAbandonedSep 22, 04Nov 13, 08[A61K, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.